TY - JOUR
T1 - Diagnosis, prevention, and treatment of catheter-aassociated urinary tract infection in adults
T2 - 2009 international clinical practice guidelines from the infectious diseases society of America
AU - Hooton, Thomas M.
AU - Bradley, Suzanne F.
AU - Cardenas, Diana D.
AU - Colgan, Richard
AU - Geerlings, Suzanne E.
AU - Rice, James C.
AU - Sanjay Saint, Saint
AU - Anthony J Schaeffer, J Schaeffer
AU - Paul A Tambayh, A Tambayh
AU - Peter Tenke, Tenke
AU - Lindsay E Nicolle, E Nicolle
N1 - Funding Information:
Potential conflicts of interest. T.M.H. has served as a consultant to Alita Pharmaceuticals. D.D.C. has served as a consultant to Coloplast A/ S, has received research funding from Coloplast A/C and AstraTech and has received honoraria from Alita Pharmaceuticals. A.J.S. has served as a consultant to Pfizer, Novabay Pharmaceuticals, Exoxemis, Alita Pharmaceuticals, American Medical Systems, Monitor Company Group, Propagate Pharma, Hagen/Sinclair Research Recruiting, and Advanstar Communications; has received honoraria from Haymarket Media, CombinatoRx, The Scientific Consulting Group, and the Multidisciplinary Alliance Against Device–Related Infections; and has received other remuneration from the American Society of Microbiology and the American Urological Association. S.E.G. has served as a consultant to and received honoraria from Merck, GlaxoSmithKline, Bristol-Myers Squibb, and AstraZeneca. S.S. has received honoraria from VHA. P.A.T. has received research support from Baxter, Merck, Pfizer, Merlion Pharma, and Interimmune. R.C. has served as consultant to Johnson & Johnson. L.E.N. has served as a consultant to Pfizer, Johnson & Johnson, and Leo Pharmaceuticals. All other authors: no conflicts.
PY - 2010/3/1
Y1 - 2010/3/1
N2 - Guidelines for the diagnosis, prevention, and management of persons with catheter-associated urinary tract infection (CA-UTI), both symptomatic and asymptomatic, were prepared by an Expert Panel of the Infectious Diseases Society of America. The evidence-based guidelines encompass diagnostic criteria, strategies to reduce the risk of CA-UTIs, strategies that have not been found to reduce the incidence of urinary infections, and management strategies for patients with catheter-associated asymptomatic bacteriuria or symptomatic urinary tract infection. These guidelines are intended for use by physicians in all medical specialties who perform direct patient care, with an emphasis on the care of patients in hospitals and long-term care facilities.
AB - Guidelines for the diagnosis, prevention, and management of persons with catheter-associated urinary tract infection (CA-UTI), both symptomatic and asymptomatic, were prepared by an Expert Panel of the Infectious Diseases Society of America. The evidence-based guidelines encompass diagnostic criteria, strategies to reduce the risk of CA-UTIs, strategies that have not been found to reduce the incidence of urinary infections, and management strategies for patients with catheter-associated asymptomatic bacteriuria or symptomatic urinary tract infection. These guidelines are intended for use by physicians in all medical specialties who perform direct patient care, with an emphasis on the care of patients in hospitals and long-term care facilities.
UR - http://www.scopus.com/inward/record.url?scp=76749145037&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=76749145037&partnerID=8YFLogxK
U2 - 10.1086/650482
DO - 10.1086/650482
M3 - Review article
C2 - 20175247
AN - SCOPUS:76749145037
VL - 50
SP - 625
EP - 663
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
SN - 1058-4838
IS - 5
ER -
